Optimization of seizure prevention by cannabidiol (CBD)
Abstract Objective: Cannabidiol (CBD) is one of the most prominent non-psychotropic cannabinoids with known therapeutic potentials. Based on its anti-seizure…
Abstract Objective: Cannabidiol (CBD) is one of the most prominent non-psychotropic cannabinoids with known therapeutic potentials. Based on its anti-seizure…
Abstract Background: Cannabis and its derivatives show encouraging therapeutic effects in the treatment of various diseases. However, further studies are…
Abstract Plain language summary: Epidiolex® (cannabidiol) is approved for treating seizures in Lennox–Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex.…
Abstract The interest in the potential therapeutic use of cannabis, especially cannabidiol (CBD), has increased significantly in recent years. On…
Abstract Simple Summary: Cannabinoids have been widely used for pain, nausea, and appetite stimulation, and have also shown anti-tumor activity…
Abstract Background: The legalization of hemp in the USA has led to tremendous growth in the availability of hemp-derived products,…
Abstract The antineoplastic effects of cannabis have been known since 1975. Since the identification of the components of the endogenous…
Abstract Graphic abstract: Article type: Review Article Keywords: Phytocannabinoid, Δ, Cannabidiol, SARS-CoV2, Covid-19, Dronabinol, Epidiolex Authors: Neda Tadayon, Ali Ramazani…
Abstract This review aims to present completed clinical trial data surrounding the medicinal benefits and potential side effects of the…
Abstract Cannabis users have long reported therapeutic properties of the plant for a variety of conditions, some of which include…